Fintan Keegan

2013

In 2013, Fintan Keegan earned a total compensation of $2.1M as Executive Vice President, Technical Operations at Jazz Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$260,000
Option Awards$695,750
Salary$356,667
Stock Awards$739,125
Other$27,300
Total$2,078,842

Keegan received $739.1K in stock awards, accounting for 36% of the total pay in 2013.

Keegan also received $260K in non-equity incentive plan, $695.8K in option awards, $356.7K in salary and $27.3K in other compensation.

Rankings

In 2013, Fintan Keegan's compensation ranked 3,787th out of 12,286 executives tracked by ExecPay. In other words, Keegan earned more than 69.2% of executives.

ClassificationRankingPercentile
All
3,787
out of 12,286
69th
Division
Manufacturing
1,285
out of 4,612
72nd
Major group
Chemicals And Allied Products
347
out of 1,466
76th
Industry group
Drugs
242
out of 1,160
79th
Industry
Pharmaceutical Preparations
197
out of 890
78th
Source: SEC filing on June 12, 2014.

Keegan's colleagues

We found four more compensation records of executives who worked with Fintan Keegan at Jazz Pharmaceuticals in 2013.

2013

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2013

Suzanne Hooper

Jazz Pharmaceuticals

General Counsel

2013

Kathryn Falberg

Jazz Pharmaceuticals

Chief Financial Officer

2013

Russell Cox

Jazz Pharmaceuticals

Chief Operating Officer

You may also like